{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:55:36Z","timestamp":1793501736415,"version":"4.5.0"},"reference-count":46,"publisher":"The Endocrine Society","issue":"2","license":[{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Foundation for Research and Education Excellence"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome (PCOS) is the most common endocrine disorder of reproductive-aged women, affecting approximately 5% to 20% of women of reproductive age. The economic burden of PCOS was previously estimated at approximately $3.7 billion annually in 2020 USD when considering only the costs of the initial diagnosis and of reproductive endocrine morbidities, without considering the costs of pregnancy-related and long-term morbidities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to estimate the excess prevalence and economic burden of pregnancy-related and long-term health morbidities attributable to PCOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PubMed, EmBase, and Cochrane Library were searched, and studies were selected in which the diagnosis of PCOS was consistent with the Rotterdam, National Institutes of Health, or Androgen Excess and PCOS Society criteria, or that used electronic medical record diagnosis codes, or diagnosis based on histopathologic sampling. Studies that included an outcome of interest and a control group of non-PCOS patients who were matched or controlled for body mass index were included. Two investigators working independently extracted data on study characteristics and outcomes. Data were pooled using random effects meta-analysis. The I2 statistic was used to assess inter-study heterogeneity. The quality of selected studies was assessed using the Newcastle-Ottawa Scale.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The additional total healthcare-related economic burden of PCOS due to pregnancy-related and long-term morbidities in the United States is estimated to be $4.3 billion annually in 2020 USD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Together with our prior analysis, the economic burden of PCOS is estimated at $8 billion annually in 2020 USD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgab613","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T09:01:34Z","timestamp":1632214894000},"page":"575-585","source":"Crossref","is-referenced-by-count":206,"title":["Health Care-Related Economic Burden of Polycystic Ovary Syndrome in the United States: Pregnancy-Related and Long-Term Health Consequences"],"prefix":"10.1210","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9890-2771","authenticated-orcid":false,"given":"Carrie","family":"Riestenberg","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, UCLA, Los Angeles, CA 90095, USA"},{"name":"The Wharton School, University of Pennsylvania, Philadelphia, PA 19104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anika","family":"Jagasia","sequence":"additional","affiliation":[{"name":"The Wharton School, University of Pennsylvania, Philadelphia, PA 19104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Markovic","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine and Health Services Research, UCLA, Los Angeles, CA 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard P","family":"Buyalos","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, UCLA, Los Angeles, CA 90095, USA"},{"name":"Fertility and Surgical Associates of California, Thousand Oaks, CA 91361, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3917-0483","authenticated-orcid":false,"given":"Ricardo","family":"Azziz","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, UCLA, Los Angeles, CA 90095, USA"},{"name":"Department of Health Policy, Management and Behavior, School of Public Health, University at Albany, SUNY, Albany, NY 12222, USA"},{"name":"Department of Obstetrics & Gynecology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA"},{"name":"Department of Healthcare Organization and Policy, School of Public Health, University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2021,9,21]]},"reference":[{"key":"2022011805243715500_CIT0001","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/AOG.0000000000002698","article-title":"Reproductive endocrinology and infertility: clinical expert series polycystic ovary syndrome","volume":"132","author":"Azziz","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2022011805243715500_CIT0002","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/09513598709023610","article-title":"Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies","volume":"1","author":"Hull","year":"1987","journal-title":"Gynecol Endocrinol."},{"issue":"3","key":"2022011805243715500_CIT0003","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/s-0037-1603096","article-title":"Polycystic ovarian syndrome: long-term health consequences","volume":"35","author":"Zore","year":"2017","journal-title":"Semin Reprod Med."},{"issue":"4","key":"2022011805243715500_CIT0004","doi-asserted-by":"crossref","first-page":"e16541","DOI":"10.2196\/16541","article-title":"Measures of patient dissatisfaction with health care in polycystic ovary syndrome: retrospective analysis","volume":"22","author":"Hoyos","year":"2020","journal-title":"J Med Internet Res."},{"issue":"12","key":"2022011805243715500_CIT0005","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1210\/jc.2017-01415","article-title":"Perspectives on polycystic ovary syndrome: is polycystic ovary syndrome research underfunded?","volume":"102","author":"Brakta","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"key":"2022011805243715500_CIT0006","author":"Eunice Kennedy Shriver National Institute of Child Health and Human Development."},{"issue":"8","key":"2022011805243715500_CIT0007","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1210\/jc.2005-0628","article-title":"Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span","volume":"90","author":"Azziz","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"key":"2022011805243715500_CIT0008","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ."},{"key":"2022011805243715500_CIT0009","author":"Riestenberg","year":"2021"},{"issue":"3","key":"2022011805243715500_CIT0010","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials."},{"key":"2022011805243715500_CIT0011","first-page":"337","article-title":"Diagnostic criteria for polycystic ovary syndrome; towards a rational approach","volume-title":"Polycystic ovary syndrome","author":"Zawadzki","year":"1992"},{"key":"2022011805243715500_CIT0012","first-page":"19","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks reated to polycystic ovary syndrome","author":"Fauser","year":"2004","journal-title":"Hum Reprod"},{"issue":"11","key":"2022011805243715500_CIT0013","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"key":"2022011805243715500_CIT0014","author":"National Institutes of Health","year":"2012"},{"issue":"9","key":"2022011805243715500_CIT0015","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede","year":"2018","journal-title":"Hum Reprod."},{"issue":"6","key":"2022011805243715500_CIT0016","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.fertnstert.2005.11.051","article-title":"Family size in women with polycystic ovary syndrome","volume":"85","author":"Pall","year":"2006","journal-title":"Fertil Steril."},{"issue":"10","key":"2022011805243715500_CIT0017","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1093\/humrep\/dez159","article-title":"Fecundity among women with polycystic ovary syndrome (PCOS)-a population-based study","volume":"34","author":"Persson","year":"2019","journal-title":"Hum Reprod."},{"key":"2022011805243715500_CIT0018","volume-title":"Health Care Expenditures for Uncomplicated Pregnancies, 2009","author":"Rohde","year":"2012"},{"key":"2022011805243715500_CIT0019","author":"U.S. Bureau of Labor Statistics","year":"2021"},{"issue":"5","key":"2022011805243715500_CIT0020","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.fertnstert.2009.10.043","article-title":"Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes","volume":"94","author":"Palomba","year":"2010","journal-title":"Fertil Steril."},{"issue":"13","key":"2022011805243715500_CIT0021","first-page":"1","article-title":"Births: final data for 2018","volume":"68","author":"Martin","year":"2019","journal-title":"Natl Vital Stat Rep."},{"issue":"6","key":"2022011805243715500_CIT0022","doi-asserted-by":"crossref","first-page":"558.e1","DOI":"10.1016\/j.ajog.2011.03.021","article-title":"Pregnancy outcomes in women with polycystic ovary syndrome: a metaanalysis","volume":"204","author":"Kjerulff","year":"2011","journal-title":"Am J Obstet Gynecol."},{"key":"2022011805243715500_CIT0023","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1477-7827-11-56","article-title":"Obstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"11","author":"Qin","year":"2013","journal-title":"Reprod Biol Endocrinol."},{"key":"2022011805243715500_CIT0024","first-page":"657","article-title":"Increased maternal pregnancy complications in polycystic ovary syndrome appear to be independent of obesity\u2014A systematic review, meta-analysis, and meta-regression","author":"Bahri Khomami","year":"2019","journal-title":"Obes Rev"},{"key":"2022011805243715500_CIT0025","article-title":"Association between polycystic ovary syndrome and the risk of pregnancy complications A PRISMA-compliant systematic review and meta-analysis","volume":"95","author":"Yu","year":"2016","journal-title":"Med (United States)"},{"key":"2022011805243715500_CIT0026","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm6743a2","article-title":"Prevalence and changes in preexisting diabetes and gestational diabetes among women who had a live birth\u2014United States, 2012\u20132016","author":"Deputy","year":"2018","journal-title":"Morb Mortal Wkly Rep"},{"issue":"5","key":"2022011805243715500_CIT0027","first-page":"1122","article-title":"Hypertension in women of reproductive age in the United States: NHANES 1999-2008","volume":"122","author":"Bateman","year":"2012","journal-title":"PLoS One"},{"issue":"16","key":"2022011805243715500_CIT0028","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1001\/jama.2017.3439","article-title":"Screening for Preeclampsia US preventive services task force recommendation statement","volume":"317","author":"Bibbins-Domingo","year":"2017","journal-title":"JAMA."},{"key":"2022011805243715500_CIT0029","first-page":"1122","article-title":"Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy","author":"American College of Obstetricians, Task Force on Hypertension in Pregnancy","year":"2013","journal-title":"Obstetrics and Gynecology"},{"issue":"4","key":"2022011805243715500_CIT0030","doi-asserted-by":"crossref","first-page":"326.e1","DOI":"10.1016\/j.ajog.2012.06.048","article-title":"Gestational diabetes screening with the new IADPSG guidelines: a cost-effectiveness analysis","volume":"207","author":"Mission","year":"2012","journal-title":"Am J Obstet Gynecol."},{"key":"2022011805243715500_CIT0031","volume-title":"Costs of Gestational Hypertensive Disorders in California: Hypertension, Preeclampsia, and Eclampsia","author":"Pourat","year":"2013"},{"key":"2022011805243715500_CIT0032","doi-asserted-by":"crossref","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat Rev Dis Primers."},{"issue":"6","key":"2022011805243715500_CIT0033","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.fertnstert.2017.09.004","article-title":"Polycystic ovary syndrome is a risk factor for diabetes and prediabetes in middle-aged but not elderly women: a long-term population-based follow-up study","volume":"108","author":"Kazemi Jaliseh","year":"2017","journal-title":"Fertil Steril."},{"key":"2022011805243715500_CIT0034","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2337\/dci18-0007","article-title":"Economic costs of diabetes in the U.S. in 2017","volume":"41","author":"Yang","year":"2018","journal-title":"Diabetes Care"},{"issue":"12","key":"2022011805243715500_CIT0035","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1080\/09513590701705189","article-title":"Polycystic ovary syndrome: a follow-up study on diabetes mellitus, cardiovascular disease and malignancy 15-25 years after ovarian wedge resection","volume":"23","author":"Lunde","year":"2007","journal-title":"Gynecol Endocrinol."},{"issue":"4","key":"2022011805243715500_CIT0036","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/humrep\/15.4.785","article-title":"Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome","volume":"15","author":"Cibula","year":"2000","journal-title":"Hum Reprod."},{"issue":"12","key":"2022011805243715500_CIT0037","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1210\/jc.2011-1677","article-title":"Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study","volume":"96","author":"Schmidt","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2022011805243715500_CIT0038","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2265.2000.01000.x","article-title":"Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study","volume":"52","author":"Wild","year":"2000","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"6","key":"2022011805243715500_CIT0039","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.thromres.2015.10.022","article-title":"Assessing the intersection of cardiovascular disease, venous thromboembolism, and polycystic ovary syndrome","volume":"136","author":"Okoroh","year":"2015","journal-title":"Thromb Res."},{"key":"2022011805243715500_CIT0040","author":"National Center for Health Statistics."},{"key":"2022011805243715500_CIT0041","author":"Khavjou"},{"key":"2022011805243715500_CIT0042","author":"Centers for Disease Control and Prevention"},{"issue":"3","key":"2022011805243715500_CIT0043","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0015-0282(16)54892-4","article-title":"Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones","volume":"57","author":"Dahlgren","year":"1992","journal-title":"Fertil Steril."},{"issue":"6","key":"2022011805243715500_CIT0044","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.fertnstert.2017.09.034","article-title":"Does the risk of diabetes and heart disease in women with polycystic ovary syndrome lessen with age?","volume":"108","author":"Azziz","year":"2017","journal-title":"Fertil Steril."},{"issue":"3","key":"2022011805243715500_CIT0045","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/humupd\/dmv063","article-title":"Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis","volume":"22","author":"Naderpoor","year":"2016","journal-title":"Hum Reprod Update."},{"issue":"12","key":"2022011805243715500_CIT0046","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1210\/jc.2013-2385","article-title":"Lifestyle modification programs in polycystic ovary syndrome: systematic review and meta-analysis","volume":"98","author":"Domecq","year":"2013","journal-title":"J Clin Endocrinol Metab."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgab613\/40469638\/dgab613.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/2\/575\/42224432\/dgab613.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/2\/575\/42224432\/dgab613.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:25:28Z","timestamp":1642465528000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/107\/2\/575\/6371160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,21]]},"references-count":46,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,9,21]]},"published-print":{"date-parts":[[2022,1,18]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgab613","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,2,1]]},"published":{"date-parts":[[2021,9,21]]}}}